ESG

CEOs Talk About 2020 Leadership And The Future

by Robert Reiss
Article

Probably the most frequently mentioned quote I’ve heard during this pandemic is by Lenin, "There are decades where nothing happens; and there are weeks where decades happen". Clearly, 2020 has dramatically escalated business transformation – both in terms of challenges and opportunities.

Lively Discussions: The Move Toward Harmonized Corporate ESG / Sustainability Reporting

G&A's Sustainability Highlights (09.18.2020)
Newsletter

There are lively discussions going on, centered on improving publicly-traded company disclosure and reporting – and especially ESG reporting…that is, storytelling about the company’s “non-financials” (in accounting-speak). 

The proliferation of ESG / sustainability reporting frameworks, standards, information platforms, industry guidance, stock exchange guidance and much more has been astounding in recent years.

The Virtual Stage Is Set! 3BL Forum Returns This October

The 3BL Virtual Forum will explore corporate leadership over the past seven months and what’s expected of business over the next year. Register today. There is no cost to register.
Blog

2020 will be remembered for many things: a global pandemic, protests for racial equity, historic wildfires, economic uncertainty in an election year. 

Novartis Reinforces Commitment to Patient Access, Pricing a EUR 1.85 Billion Sustainability-linked Bond

Summary: 
  • First healthcare industry sustainability-linked bond (SLB) further embeds Environmental Social Governance (ESG) targets into the core of Novartis business operations
  • SLB linked to 2025 Patient Access Targets to increase patients reached in low- and middle-income countries (LMICs) with strategic innovative therapies by 200% and the Novartis Flagship Programs by 50%
Press Release
  • First healthcare industry sustainability-linked bond (SLB) further embeds Environmental Social Governance (ESG) targets into the core of Novartis business operations
  • SLB linked to 2025 Patient Access Targets to increase patients reached in low- and middle-income countries (LMICs) with strategic innovative therapies by 200% and the Novartis Flagship Programs by 50%

Working With Nature: Improving Ecosystems and Business Costs

By demonstrating the value of natural capital, our goal is to inspire actions that accelerate adoption of green infrastructure solutions around the globe.
Blog

Five years ago, Dow made a big bet. This bet was based on the premise that there was a lot of unaccounted value from nature, and a lot of nature-based solutions to be discovered for business problems.

The Financial Sector & Corporate Universe - the “ESG Factors” Are Now Everywhere When Companies Seek Capital

G&A's Sustainability Highlights (09.03.2020)
Newsletter

The roots of today’s “sustainable investing” approaches go back decades; the organizing principle often was often around  what investors viewed as “socially responsible”, “ethical”, “faith-based” and “values” investing.  “SRI” over time evolved into the more dominant sustainable or ESG investing in the 21st Century -- with many more mainstream investors today embracing the approach. 

"Build Back Better": COVID-19 Brings the "S" From ESG Into Focus

by Julie Moret, Head of ESG, Franklin Templeton
Blog

Dislocations resulting from the pandemic shine a light on environmental, social and governance (ESG) issues, which can be used as an additional tool to identify leading companies from the laggards, according to Franklin Templeton’s Global Head of ESG, Julie Moret. She explains why she believes the pandemic has propelled “S” issues to the forefront, and how this environment could cultivate a fertile backdrop for active management.

Read the full article here.

Pages

Subscribe to ESG